Return to Supplemental Budgets

---

Agency 303

Department of Health

Recommendation Summary

Dollars in Thousands

																								FY 97 FTEs											General Fund-State					Other Funds			Total Funds
1995-97 Expenditure Authority																						1,128.1												88,967					353,430			442,397
Supplemental Changes
HIV/AIDS Prescription Drug Program																																		1,761								1,761
Subtotal - Supplemental Changes																																		1,761								1,761
Total Proposed Budget																						1,128.1												90,728					353,430			444,158
Difference																																		1,761								1,761
Percent Change from Current Biennium																																		2.0%								.4%

Supplemental Changes

HIV/AIDS Prescription Drug Program
New pharmaceutical treatments are emerging as the standard of care for HIV treatment. Protease inhibitors used in combination with other antiretroviral medication are managing HIV viral load levels thereby enhancing the health and ability to remain employed for persons with HIV. Recent cost estimates indicate that current funding is not sufficient to support this program through Fiscal Year 1997. This funding assumes rebates of up to 15 percent for some of the new drugs. The following increases are estimated from May 1996 to June 1997: (1) enrollment from 813 to 1,150; (2) per capital costs from $400 per month to $600 per month; and (3) utilization from 32.5 percent to 50 percent.